Robert Crane - Mar 16, 2022 Form 4 Insider Report for Axcella Health Inc. (AXLA)

Role
Chief Financial Officer
Signature
By: /s/ Paul Fehlner, Attorney-in-Fact
Stock symbol
AXLA
Transactions as of
Mar 16, 2022
Transactions value $
$0
Form type
4
Date filed
3/18/2022, 05:39 PM
Previous filing
Feb 28, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AXLA Stock Option (Right to Buy) Award $0 +125K $0.00 125K Mar 16, 2022 Common Stock 125K $1.63 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On February 8, 2022, the Reporting Person was granted an option to purchase 125,000 shares of AXLA common stock, subject to the satisfaction of certain performance criteria. On March 16, 2022, the Issuer's Compensation Committee confirmed that the performance criteria had been met.
F2 25% of the shares underlying this option shall vest and become exercisable on February 8, 2023, with the remainder vesting in twelve equal quarterly installments thereafter, subject to subject to Reporting Person's continued service on each such vesting date.